Literature DB >> 2823023

Selective tropism of bovine leukemia virus (BLV) for surface immunoglobulin-bearing ovine B lymphocytes.

D Lévy1, R Kettmann, P Marchand, S Djilali, A L Parodi.   

Abstract

Bovine leukemia virus (BLV) is experimentally infectious for sheep. Virus production does not occur in the animals, but only after in vitro cultivation of infected lymphocytes in the presence of phytohemagglutinin. Lipopolysaccharide or dextran sulfate 500 had no effect. After panning separation, it was possible to demonstrate that, in peripheral blood lymphocytes, BLV was integrated in the B lymphocytes only and that BLV expression took place in a fraction of this population. The ovine leukemia may constitute a good experimental model for understanding the virus-induced leukemias of the BLV-human T cell leukemia virus group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823023

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

1.  Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.

Authors:  B E Fulton; M Portella; K Radke
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity.

Authors:  D Derse; L Martarano
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation.

Authors:  W A Ferens; C J Hovde
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle.

Authors:  I Schwartz; A Bensaid; B Polack; B Perrin; M Berthelemy; D Levy
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Inhibition of protein kinase C results in decreased expression of bovine leukemia virus.

Authors:  W A Jensen; B J Wicks-Beard; G L Cockerell
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.